3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
34
Pemetrexed
27
Drug Therapy
22
Cisplatin
22
osimertinib
18
aflutinib
11
Paclitaxel
11
pembrolizumab
10
Surgical Procedures, Operative
10
Docetaxel
10
tislelizumab
9
Radiotherapy
8
Magnetic Resonance Spectroscopy
8
anlotinib
7
Specimen Handling
7
Bevacizumab
7
130-nm albumin-bound paclitaxel
7
toripalimab
6
cemiplimab
6
Immunotherapy
6
sintilimab
5
ensartinib
5
durvalumab
5
Radiosurgery
5
Platinum Compounds
5
Nivolumab
5
trametinib
4
aumolertinib
4
Observation
4
Injections
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma, Non-Small-Cell Lung
×
JDQ443
×
Clear all
NCT07468071
2026-04-02
KontRASt-R
Novartis
Phase 1/2
Not yet recruiting
40 enrolled